Long-term Use of Spiolto Respimat in Japanese Patients With Chronic Obstructive Pulmonary Disease

NCT02850978 · clinicaltrials.gov ↗

COMPLETED

Status

1335

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Spiolto

Sponsor

Boehringer Ingelheim